NCT06258564View on ClinicalTrials.gov

The Adjuvant Effect of HPV Vaccination on Recurrence of Cervical Precancer or Carcinoma in Women Undergoing Conization

CompletedOBSERVATIONAL
Enrollment

12,000

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

January 30, 2025

Conditions
Cervical Intraepithelial Neoplasia Grade 2/3Recurrence
Interventions
BIOLOGICAL

vaccination against human papillomavirus infection (HPV vaccination)

Women with or without HPV vaccination before or after excision

Trial Locations (2)

10000

Department of Epidemiology and Biostatistics, Third Faculty of Medicine, Charles University, Prague

16000

Unilabs Pathology K.S, Prague

All Listed Sponsors
lead

Charles University, Czech Republic

OTHER

NCT06258564 - The Adjuvant Effect of HPV Vaccination on Recurrence of Cervical Precancer or Carcinoma in Women Undergoing Conization | Biotech Hunter | Biotech Hunter